Ribi Immunochem (ribi) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ribi Immunochem (ribi)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Bill Tomko who wrote (28)	3/22/1997 11:03:00 PM
From: tim quane	of 92

Bill the news release of jan. 7th states that sbh will be taking an equity position over the next 3 years. this however was the first details that i,ve seen. as i see it sbh controls ribi. ribi has put to many eggs in one basket. one example is the hepatitis vaccine. it is well known it is much better than the current vaccine but since sbh leads the market in that position they are dragging there feet because they dont want to pay ribi when they are making good money now. also in the 1996 report ribi suggest that the herpes vaccine could be completed by the end of the year, then the beginning of 1997 then mid 97 now the end of 97. my position tho is to still hold ribi for the long term. the mpl-c is looking good and they are looking for a corperate partner there. biomira situation looks good,and they need a corporate partner for melacine (im hoping for sgp).the herpes vaccine is only a year and a half away and i dont beleive sbh is going to pay ribi royalities if all the adjuvent vaccines start producing. i do believe that ribi needs much better management and always vote against them.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next